HIGHLIGHTS
- who: Sha Yang from the Center for Molecular Imaging Probe, Hunan Province Key Laboratory Cancer Research Institute, University of South China, Hengyang , have published the Article: A mitochondria-targeted molecular phototheranostic platform for NIR-II imaging-guided synergistic photothermal/photodynamic/immune therapy, in the Journal: (JOURNAL)
- what: This work provides a practicable strategy to develop a molecular phototheranostic platform for imaging-guided cancer therapy via mitochondria-targeting.
- how: These results indicated that the FEPT can afford a steady NIR-II imaging. To evaluate the in_vivo stability of FEPT the absorbance and NIR-II . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.